Pharmafile Logo
Pharmafocus logo
Advanced Search

femara

Showing 3 posts of 3 posts found.

Pfizer gets early approval for breast cancer drug

February 4, 2015
Sales and Marketing FDA, Pfizer, Xalkori (crizotinib), axitinib, bosulif, bosutinib, femara, ibrance, inlyta, letrozole, palbociclib

The FDA has shown Pfizer’s breast cancer drug Ibrance an early green light to treat patients who are at the …

News
Pfizer New York HQ

Pfizer to submit breast cancer drug

May 18, 2014
Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib

Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …

News

Pfizer breast cancer drug shows promise

February 4, 2014
Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial.  The pill was administered …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025